Metraipolis › archive › dc_bf0ab7752e20
Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics — Europe PMC PMID:42247154
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42247154
- DOI
- 10.1186/s43556-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T19:09:42.897Z
- SHA-256 of the archived text
12440b337a59a5b3c8c64a15e604a54df2ec7eae8a5d04bf8e5c8e0c504f49d6- Stable URL of this page
https://metraipolis.com/documento/dc_bf0ab7752e20
How to cite
Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics — Europe PMC PMID:42247154 — Europe PMC (en), https://europepmc.org/article/MED/42247154 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf0ab7752e20 (Metraipolis archive dc_bf0ab7752e20, sha256 12440b337a59a5b3c8c64a15e604a54df2ec7eae8a5d04bf8e5c8e0c504f49d6)
BibTeX
@misc{dcbf0ab7752e20,
title = {Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics — Europe PMC PMID:42247154},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42247154},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf0ab7752e20; sha256 12440b337a59a5b3c8c64a15e604a54df2ec7eae8a5d04bf8e5c8e0c504f49d6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42247154. Agents can read the archived copy with the MCP tool read_document.